Sharathchandra S Hegde Net Worth & Insider Trades
Sharathchandra S Hegde - SVP, Theravance Biopharma, Inc
What is Sharathchandra S Hegde's Net Worth?
The current estimated net worth of Theravance Biopharma, Inc's SVP, Sharathchandra S Hegde, is estimated to be about $2.92M . Sharathchandra S Hegde owns about 264,444 units of Theravance Biopharma, Inc common stock. In the last 3 years at Theravance Biopharma, Inc, Sharathchandra S Hegde has sold an estimated value of $1.7M worth.
What is Sharathchandra S Hegde's Past Insider Trading?
Sharathchandra S Hegde's largest sale order was 9,033 units , worth over $223.17K on March 6, 2019. In total, Sharathchandra S Hegde has made about 14 transactions over 3 years of their time at Theravance Biopharma, Inc. Sharathchandra S Hegde usually trades in February, with the busiest year in 2018.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SHARATHCHANDRA HEGDE
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Sharathchandra S Hegde's' Mailing Address?
- Mailing address is 901 Gateway Blvd South San Francisco CA 94080 CA
Theravance Biopharma, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Other Earnings Plans or Compensations
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
---|---|---|---|---|---|---|---|---|
Rick E Winningham | 2020 | $1,014,455 | - | $579,646 | - | $579,646 | $6,045 | $6,577,746 |
Rick E Winningham | 2019 | $983,710 | - | $473,906 | - | $473,906 | $5,496 | $5,932,411 |
Rick E Winningham | 2018 | $956,600 | $74,767 | $690,154 | - | $690,154 | $5,000 | $2,522,841 |
Andrew A. Hindman | 2020 | $551,608 | - | $265,278 | - | $265,278 | $5,920 | $2,097,950 |
Andrew A. Hindman | 2019 | $315,000 | $175,000 | $216,000 | $2,204,956 | $216,000 | - | $3,757,956 |
Brett Haumann | 2020 | $572,569 | - | $213,589 | - | $213,589 | $53,267 | $2,742,625 |
Brett Haumann | 2019 | $543,047 | - | $170,000 | - | $170,000 | $42,382 | $2,464,280 |
Brett Haumann | 2018 | $497,810 | $34,125 | $315,000 | - | $315,000 | $414,300 | $1,517,194 |
Vijay Sabesan | 2020 | $407,677 | - | $760,326 | - | $760,326 | $6,541 | $3,077,744 |
Bradford J. Shafer | 2020 | $556,321 | - | $264,999 | - | $264,999 | $6,045 | $2,730,565 |
Bradford J. Shafer | 2019 | $537,403 | - | $215,611 | - | $215,611 | $6,983 | $2,468,848 |
Bradford J. Shafer | 2018 | $518,080 | $33,770 | $311,726 | - | $311,726 | $5,000 | $1,124,537 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/1583107/000110465921039784/tm212357-1_def14a.htm
What are Theravance Biopharma, Inc's Past Insider Trades?
Theravance Biopharma, Inc's most recent insider trade came on November 22, 2023 by Rhonda Farnum who sold 9,360 units worth $96.95K . In the last 8 years, insiders at Theravance Biopharma, Inc have sold an estimated value of $152.42M and bought an estimated value of $26.3M worth of shares. Insider trading is most common in February, with the busiest year in 2018. The most active traders at the company are Bradford Shafer, EVP, Rick Winningham, CHIEF EXECUTIVE OFFICER, and Richard Graham, SVP .
Theravance Biopharma, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |